StockData
Roivant Sciences Ltd. logo

Roivant Sciences Ltd. (ROIV) stock

ROIVNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through Q1 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$38.71+0.10 (+0.26%)

Close on Nov 17, 2026Market cap $27.96BP/E –Yield –

Roivant Sciences total assets

Total assets on the balance sheet at the end of each period.

Roivant Sciences's total assets was $5.31B at Jun 30, 2026. For fiscal 2025 it was $5.71B, up 5.0% from the year before. The highest annual figure on record is $7.22B in fiscal 2023.

Annual total assets

PeriodPeriod endValueChange
FY2025Mar 31, 2026$5.71B+5.0%
FY2024Mar 31, 2025$5.44B-24.7%
FY2023Mar 31, 2024$7.22B+202.2%
FY2022Mar 31, 2023$2.39B-7.6%
FY2021Mar 31, 2022$2.59B-0.2%
FY2020Mar 31, 2021$2.59B–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2026CQ2 2026Jun 30, 2026$5.31B+5.4%
Q4 FY2025CQ1 2026Mar 31, 2026$5.71B+5.0%
Q3 FY2025CQ4 2025Dec 31, 2025$5.23B-9.8%
Q2 FY2025CQ3 2025Sep 30, 2025$5.06B-18.4%
Q1 FY2025CQ2 2025Jun 30, 2025$5.03B-22.5%
Q4 FY2024CQ1 2025Mar 31, 2025$5.44B-24.7%
Q3 FY2024CQ4 2024Dec 31, 2024$5.79B-20.8%
Q2 FY2024CQ3 2024Sep 30, 2024$6.21B+200.5%
Q1 FY2024CQ2 2024Jun 30, 2024$6.50B+204.0%
Q4 FY2023CQ1 2024Mar 31, 2024$7.22B+202.2%
Q3 FY2023CQ4 2023Dec 31, 2023$7.31B+231.9%
Q2 FY2023CQ3 2023Sep 30, 2023$2.07B-6.8%
Q1 FY2023CQ2 2023Jun 30, 2023$2.14B-17.8%
Q4 FY2022CQ1 2023Mar 31, 2023$2.39B-7.6%
Q3 FY2022CQ4 2022Dec 31, 2022$2.20B-21.3%
Q2 FY2022CQ3 2022Sep 30, 2022$2.22B-28.6%
Q1 FY2022CQ2 2022Jun 30, 2022$2.60B+5.9%
Q4 FY2021CQ1 2022Mar 31, 2022$2.59B-0.2%
Q3 FY2021CQ4 2021Dec 31, 2021$2.80B–
Q2 FY2021CQ3 2021Sep 30, 2021$3.10B–
Q1 FY2021CQ2 2021Jun 30, 2021$2.45B–
Q4 FY2020CQ1 2021Mar 31, 2021$2.59B–

More Roivant Sciences figures

See a number that looks wrong?